|

Percutaneous Neurostimulation in Knee Osteoarthritis

RECRUITINGN/ASponsored by Tanta University
Actively Recruiting
PhaseN/A
SponsorTanta University
Started2026-06-02
Est. completion2026-11
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Peripheral nerve stimulation (PNS) is a drug-free pain management procedure that uses electrical impulses to target specific nerves and block pain signals. PNS helps decrease perception of pain, providing real answers to patients dealing with chronic knee pain. The case study discussed in this presentation is of the use of PNS targeting the superior lateral genicular nerve and the saphenous nerve for a patient with moderate to severe knee pain from osteoarthritis

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. adults between the ages of 30 and 70 years with a clinical diagnosis of moderate to severe knee OA who suffered knee pain.
2. Patients who cannot afford intra-articular injections or radiofrequency ablation (RFA).
3. patients who had failed 2 different oral pain medications and 6 weeks of physical therapy.

Exclusion Criteria:

1. Patients with OA show improvement in pain after physiotherapy.
2. patients evaluated by an orthopaedic surgeon and deemed to be surgical candidates due to knee pathologies other than OA.
3. pregnant patients.
4. patients on anticoagulation therapy, who were not permitted to stop anticoagulation.
5. patients with previous trauma, neurological or endocrine diseases like diabetes mellitus, and knee tumors; and patients with inflammatory arthritis.
6. people who had received an intra-articular knee injection within the last 6 months.
7. Patients with tendon tears, bursitis, or calcified tendonitis as proven by imaging.

Conditions3

ArthritisNeuromodulationOsteoarthritis (OA) of the Knee

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.